| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/27/1999 | EP0893495A2 Isoleucyl tRNA synthetase from Chlamydia trachomatis |
| 01/27/1999 | EP0893494A2 Aspartyl tRNA synthetase from Chlamydia trachomatis |
| 01/27/1999 | EP0893493A2 Genetically modified cells and their use for prophylaxis or treatment of diseases |
| 01/27/1999 | EP0893142A1 Mask for treating cold |
| 01/27/1999 | EP0892801A1 Acridone-derived compounds useful as antineoplastic and antiretroviral agents |
| 01/27/1999 | EP0892795A1 Piperidinylpyramidine derivatives |
| 01/27/1999 | EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 01/27/1999 | EP0892640A2 Enteric-coated pharmaceutical compositions of mycophenolate |
| 01/27/1999 | EP0731792B1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 01/27/1999 | CN1206405A Imides as PDE III, PDE IV and TNF inhibitors |
| 01/27/1999 | CN1206350A Hybrid with interferon-'alpha' and immunoglobulin Fc linkes through non-immunogenic peptide |
| 01/27/1999 | CN1205892A Chinese medicine capsule for curing pulmonary tuberculosis |
| 01/27/1999 | CN1041793C Pharmaceutical composition of florfenicol |
| 01/26/1999 | US5864036 Substituted imidazole compounds |
| 01/26/1999 | US5864031 Process for preparing 5-dithio-modified oligonucleotides |
| 01/26/1999 | US5864028 Degradation resistant mRNA derivatives linked to TNF-α ribozymes |
| 01/26/1999 | US5864027 HIV envelope polypeptides |
| 01/26/1999 | US5863949 Reacting carboxylic acid derivative with 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzenetriazole and hydroxylamine; treats diseases involving production of tumor necrosis factor in a mammal |
| 01/26/1999 | US5863938 Wound healing agent comprises pyruvate selected from the group consisting of pyruvic acid, pharmaceutically acceptable salts of pyruvic acid and mixtures thereof; antioxidant; mixture of saturated and unsaturated fatty acids |
| 01/26/1999 | US5863937 Peptide conjugated compound as fungicides, bactericides, microbiocides treating candida albicans infection |
| 01/26/1999 | US5863906 Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man |
| 01/26/1999 | US5863905 2',5'-phosphorothioate/phosphodiester oligoadenylates and anti-viral uses thereof |
| 01/26/1999 | US5863796 Immunizing a mammal with specific polypeptide and collecting the antibody |
| 01/26/1999 | US5863777 DNA encoding alanyl tRNA synthetase from streptococcus pneumonine |
| 01/26/1999 | US5863766 Isolated, pure polynucleotide encoding a polypeptide for treating vesicle trafficking, immunological, and neoplastic disorders. |
| 01/26/1999 | US5863560 Compositions and methods for topical application of therapeutic agents |
| 01/26/1999 | US5863542 Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts |
| 01/26/1999 | CA2166692C Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/26/1999 | CA2131373C 2-aminosugar derivatives of macrolides |
| 01/26/1999 | CA2001714C Serine analogs of bu-3608 antibiotics |
| 01/25/1999 | CA2238664A1 Novel regulator |
| 01/25/1999 | CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor |
| 01/24/1999 | CA2238658A1 Novel grea |
| 01/23/1999 | CA2238682A1 Novel asps |
| 01/23/1999 | CA2238677A1 Novel iles |
| 01/23/1999 | CA2238674A1 Novel tetracycline resistance protein |
| 01/23/1999 | CA2238671A1 Novel bmru |
| 01/23/1999 | CA2238667A1 Novel ferrichrome transport atp-binding protein |
| 01/23/1999 | CA2238665A1 Novel reductase |
| 01/23/1999 | CA2238663A1 Novel hiss |
| 01/23/1999 | CA2238611A1 Novel lyss |
| 01/21/1999 | WO1999002713A1 Pseudomonas exotoxin a-like chimeric immunogens |
| 01/21/1999 | WO1999002666A2 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/21/1999 | WO1999002657A1 Rhabdoviruses with reengineered coats |
| 01/21/1999 | WO1999002563A1 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/21/1999 | WO1999002550A1 Ctl epitopes from ebv |
| 01/21/1999 | WO1999002541A2 Erythromycin a oxime solvates |
| 01/21/1999 | WO1999002525A1 Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agents |
| 01/21/1999 | WO1999002523A1 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 01/21/1999 | WO1999002496A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
| 01/21/1999 | WO1999002252A1 Improvements in or relating to capsules |
| 01/21/1999 | WO1999002185A1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/21/1999 | WO1999002183A2 A method of inducing a ctl response |
| 01/21/1999 | WO1999002178A1 Therapeutic agent for the treatment of septicaemia, its preparation and use |
| 01/21/1999 | WO1999002148A1 Nitric oxide inhibits rhinovirus infection |
| 01/21/1999 | WO1998031389A3 Fibronectin binding protein compositions, antibodies thereto, and methods of use |
| 01/21/1999 | CA2303430A1 Nitric oxide inhibits rhinovirus infection |
| 01/21/1999 | CA2295935A1 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/21/1999 | CA2295629A1 Erythromycin a oxime solvates |
| 01/21/1999 | CA2294732A1 Ctl epitopes from ebv |
| 01/21/1999 | CA2294293A1 Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agents |
| 01/21/1999 | CA2292480A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
| 01/21/1999 | CA2237698A1 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 01/20/1999 | EP0892064A2 Recombinant secA2 polypeptide from Staphylococcus aureus and uses thereof |
| 01/20/1999 | EP0892063A2 Histidine kinase |
| 01/20/1999 | EP0892062A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 01/20/1999 | EP0892061A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratB |
| 01/20/1999 | EP0892060A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA |
| 01/20/1999 | EP0892059A2 Histidine kinase polypeptides |
| 01/20/1999 | EP0892057A2 Response regulator |
| 01/20/1999 | EP0892056A2 GidA1 polypeptides from Chlamydia trachomitis |
| 01/20/1999 | EP0892055A2 GidB polypeptides from Staphylococcus aureus |
| 01/20/1999 | EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor |
| 01/20/1999 | EP0891984A2 Nucleic acid encoding streptococcus pneumoniae response regulator |
| 01/20/1999 | EP0891983A1 Novel tarF |
| 01/20/1999 | EP0891982A2 HIV peptides |
| 01/20/1999 | EP0891770A1 Killer T cell activator and use thereof |
| 01/20/1999 | EP0891429A2 Recombinant aav vector-based transduction system and use of same |
| 01/20/1999 | EP0891426A2 Human bikunin |
| 01/20/1999 | EP0891376A1 Antifungal peptides from scleroderma texense |
| 01/20/1999 | EP0891375A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity |
| 01/20/1999 | EP0891374A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 01/20/1999 | EP0891361A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891360A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891357A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891356A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891355A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891353A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891352A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891351A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891350A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891349A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891343A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891339A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891337A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891335A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891334A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891319A1 Novel benzaldehyde derivatives from hericeum erinaceus |
| 01/20/1999 | EP0891189A1 Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 01/20/1999 | EP0767657A4 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |